MPMI (drug)
3-(N-methylpyrrolidin-3-ylmethyl)indole (MPMI) is a
serotonin receptor agonist. It has been studied as an analogue and trace impurity of the anti-migraine drug eletriptan but is otherwise little known.[1][2]
See also
- α,N,N-Trimethyltryptamine
- Dimethyltryptamine
- 4-HO-MPMI
- 5F-MPMI
- 5-MeO-MPMI
- NTBT
- Pyr-T
- SN-22
References
- ^ FI 105812, Wythes MJ, Macor JE, "Menetelmä terapeuttisesti käyttökelpoisten indolijohdannaisten valmistamiseksi", issued 14 April 1993, assigned to Pfizer, Inc.
- ^ US 5607951, Macor JE, Wythes MJ, "Indole derivatives", issued 4 March 1997, assigned to Pfizer, Inc.